{
    "clinical_study": {
        "@rank": "36715", 
        "arm_group": [
            {
                "arm_group_label": "aH5N1c - High dose", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "aH5N1c - Low dose", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluate Safety, Tolerability and Immune response of adjuvanted H5N1 cell culture derived\n      influenza vaccine in elderly subjects"
        }, 
        "brief_title": "Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pandemic H5N1 Influenza", 
        "condition_browse": {
            "mesh_term": [
                "Influenza in Birds", 
                "Influenza, Human"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Healthy elderly subjects \u226565 years,\n\n          2. Individuals willing to provide written informed consent,\n\n          3. Individuals in good health,\n\n          4. Individuals willing to allow for their serum samples to be stored beyond the study\n             period.\n\n        Exclusion Criteria:\n\n          1. Individuals not able to understand and follow study procedures,\n\n          2. History of any significant illness,\n\n          3. History of any chronic medical condition or progressive disease,\n\n          4. Presence of medically significant cancer,\n\n          5. Known or suspected impairment/alteration of immune function,\n\n          6. Presence of any progressive or severe neurologic disorder,\n\n          7. Presence of any bleeding disorders or conditions that prolongs bleeding time,\n\n          8. History of allergy to vaccine components,\n\n          9. Receipt of any other investigational product within 30 days prior to entry into the\n             study,\n\n         10. History of previous H5N1 vaccination,\n\n         11. Receipt of any other type of seasonal vaccination within 2 months prior to entry into\n             the study,\n\n         12. Receipt of any other vaccine within 2 weeks prior to entry into the study\n\n         13. Body temperature \u226538\u00b0C.0 (\u2265100.4\u00b0 F) and/or acute illness within 3 days of intended\n             study vaccination,\n\n         14. Body mass index (BMI) \u2265 35 kg/m2,\n\n         15. History of drug or alcohol abuse,\n\n         16. Any planned surgery during study period,\n\n         17. Individuals conducting the study and their immediate family members,\n\n         18. Individuals with behavioral or cognitive impairment or psychiatric diseases."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "1392", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01766921", 
            "org_study_id": "V89_13"
        }, 
        "intervention": {
            "arm_group_label": [
                "aH5N1c - High dose", 
                "aH5N1c - Low dose"
            ], 
            "description": "Comparison of two doses of aH5N1c vaccine", 
            "intervention_name": "Adjuvanted  H5N1 pandemic influenza vaccine", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Influenza, Pandemic, H5N1, Elderly adults", 
        "lastchanged_date": "December 3, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85253"
                    }, 
                    "name": "1 Tatum Highlands Med Ass PLLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Florida", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33206"
                    }, 
                    "name": "5 Broward Research Group Pembroke Pines"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67207"
                    }, 
                    "name": "7 Heartland Rsrch Ass LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67207"
                    }, 
                    "name": "9 Heartland Research Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63141"
                    }, 
                    "name": "3 Saint Louis University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63141"
                    }, 
                    "name": "2 Mercy Health Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Endwell", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13760"
                    }, 
                    "name": "6 Regional Clinical Research Endwell,"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78705"
                    }, 
                    "name": "4 Benchmark Medical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Georgetown", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78745"
                    }, 
                    "name": "12 Tekton Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "South Cottonwood Heights", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84121"
                    }, 
                    "name": "10 Foothill Family Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "South Jordan", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84095"
                    }, 
                    "name": "11 Jordan River Family Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2292"
                    }, 
                    "name": "42 Hunter Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auchenflower", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4066"
                    }, 
                    "name": "44 Wesley Research Institute Clinical Trials Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Adelaide", 
                        "country": "Australia", 
                        "state": "South Australia", 
                        "zip": "5000"
                    }, 
                    "name": "40 CMAX"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nedlands", 
                        "country": "Australia", 
                        "state": "Western Australia", 
                        "zip": "6009"
                    }, 
                    "name": "41 Linear Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Perth", 
                        "country": "Australia", 
                        "state": "Western Australia", 
                        "zip": "6872"
                    }, 
                    "name": "45 Childrens Clin Rsrch Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beckenham", 
                        "country": "New Zealand", 
                        "state": "Christchurch", 
                        "zip": "8244"
                    }, 
                    "name": "50 Southern Clinical Trials"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Riccarton", 
                        "country": "New Zealand", 
                        "state": "Christchurch", 
                        "zip": "8041"
                    }, 
                    "name": "51 Riccarton Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "Thailand", 
                        "state": "UT", 
                        "zip": "84121"
                    }, 
                    "name": "8 J. Lewis Research Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "zip": "10400"
                    }, 
                    "name": "71 Phramongkutklao Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "zip": "10330"
                    }, 
                    "name": "72 Faculty of Medicine, Chulalongkorn University - Queen Saovabha Memorial Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "zip": "10700"
                    }, 
                    "name": "73 Siriraj Clinical Research Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand", 
                        "zip": "50200"
                    }, 
                    "name": "74 Chiang Mai Uni Hospital Clinical Trial Center"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "New Zealand", 
                "Thailand"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase II, Randomized, Observer-Blind, Multi-Center, Study to Evaluate Safety, Tolerability and Immunogenicity of an Adjuvanted Cell Culture-Derived H5N1 Subunit Influenza Virus Vaccine at Two Different Formulations in Healthy Elderly Subjects.", 
        "overall_official": {
            "affiliation": "Novartis Vaccines", 
            "last_name": "Novartis vaccines and Diagnostics", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration and Department of Health and Human Services", 
                "Thailand: Food and Drug Administration", 
                "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
                "New Zealand: Medsafe"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Seroprotection and Seroconversion rate measured 3 weeks after second dose of vaccine administration", 
                "measure": "To select a vaccine dose based on the achievement of CBER criteria for further development", 
                "safety_issue": "No", 
                "time_frame": "Day 43 (3 weeks after second vaccination)"
            }, 
            {
                "measure": "Percentage of subjects with solicited local and systemic adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "7 days post vaccination"
            }, 
            {
                "measure": "Percentage of subjects with unsolicited adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "3 weeks post vaccination"
            }, 
            {
                "measure": "Percentage of subjects with serious adverse events, medically attended adverse events, adverse events leading to withdrawal and adverse events of special interest", 
                "safety_issue": "Yes", 
                "time_frame": "Throughout the study"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01766921"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Seroprotection, Seroconversion rate and GMRs measured 3 weeks after second dose of vaccine administration", 
                "measure": "Achievement of CHMP criteria 3 weeks after after second dose of vaccine administration", 
                "safety_issue": "No", 
                "time_frame": "Day 43"
            }, 
            {
                "description": "Seroprotection, Seroconversion rate and GMRs measured  3 weeks after first dose of vaccine administration", 
                "measure": "Achievement of CBER and CHMP criteria 3 weeks after first dose of vaccine administration", 
                "safety_issue": "No", 
                "time_frame": "Day 22"
            }, 
            {
                "description": "Seroprotection, Seroconversion rate and GMRs measured  3 weeks after booster dose of vaccine administration", 
                "measure": "Achievement of CBER and CHMP criteria 3 weeks after booster dose of vaccine administration", 
                "safety_issue": "No", 
                "time_frame": "Day 387"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "collaborator": {
                "agency": "Department of Health and Human Services", 
                "agency_class": "U.S. Fed"
            }, 
            "lead_sponsor": {
                "agency": "Novartis Vaccines", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}